The Glymphatic System in Diabetes-Induced Dementia

Abstract

The glymphatic system has emerged as an important player in central nervous system (CNS) diseases, by regulating the vasculature impairment, effectively controlling the clearance of toxic peptides, modulating activity of astrocytes, and being involved in the circulation of neurotransmitters in the brain. Recently, several studies have indicated decreased activity of the glymphatic pathway under diabetes conditions such as in insulin resistance and hyperglycemia. Furthermore, diabetes leads to the disruption of the blood-brain barrier and decrease of apolipoprotein E (APOE) expression and the secretion of norepinephrine in the brain, involving the impairment of the glymphatic pathway and ultimately resulting in cognitive decline. Considering the increased prevalence of diabetes-induced dementia worldwide, the relationship between the glymphatic pathway and diabetes-induced dementia should be investigated and the mechanisms underlying their relationship should be discussed to promote the development of an effective therapeutic approach in the near future. Here, we have reviewed recent evidence for the relationship between glymphatic pathway dysfunction and diabetes. We highlight that the enhancement of the glymphatic system function during sleep may be beneficial to the attenuation of neuropathology in diabetes-induced dementia. Moreover, we suggest that improving glymphatic system activity may be a potential therapeutic strategy for the prevention of diabetes-induced dementia.

Risk of neurodegenerative dementia in asthma patients: a nested case–control study using a national sample cohort

“…Because older adults have a higher number of comorbidities such as cardiovascular and metabolic diseases, the impact of these systemic disorders on neurodegenerative changes is anticipated to grow. Consistent with these findings, numerous studies have reported associations of various chronic diseases, including hypertension, diabetes, dyslipidaemia, coronary heart disease and depression, with dementia 3–6…”

Traumatic brain injury in older adults: shining light on a growing public health crisis

“…Two articles in this issue examine the specific issue of sleep disturbances following TBI in older adults. This is an extremely important neuropsychiatric symptom given the mounting evidence that during sleep the brain enhances glymphatic pathway clearance of metabolites and modulates activity of astrocytes (Kim, Nam, & Song, 2018). In this issue, Albrecht and Wickwire show that older adults diagnosed with TBI were more likely than those without to have new onset sleep disorders both before and after the TBI.…”

Diabetes and dementia – the two faces of Janus

“…The glymphatic brain system represents the glial component of the outer boundary of the perivascular space, which plays a crucial role in the clearance and turnover of substances between the brain parenchyma and the vessels. This system is severely affected in degenerative disease like AD [ 44 ]. The main mechanism of glymphatic system dysfunction in AD is the lack of efficiency in Aβ clearance because toxic amyloid can be transported via low-density lipoprotein-related receptor I [ 45 ].…”